The current performance bottlenecks of artificial intelligence (AI) models in predicting EGFR mutations in non-small cell lung cancer (NSCLC) primarily stem from fragmented data ecosystems and a lack of standardization. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.